Qyuns Therapeutics Co., Ltd. (HKG:2509)
Hong Kong · Delayed Price · Currency is HKD 16.97
+0.19 (1.13%)
Aug 21, 2026, 3:45 PM HKT
Qyuns Therapeutics Revenue
Qyuns Therapeutics had revenue of 600.48M CNY in the half year ending December 31, 2025. This brings the company's revenue in the last twelve months to 1.02B, up 219.81% year-over-year. In the year 2025, Qyuns Therapeutics had annual revenue of 806.96M with 408.18% growth.
Revenue (ttm)
1.02B CNY
Revenue Growth
+219.81%
P/S Ratio
3.20
Revenue / Employee
3.04M CNY
Employees
337
Market Cap
3.79B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 806.96M | 648.17M | 408.18% |
| Dec 31, 2024 | 158.79M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 9.66M | -11.69M | -54.74% |
| Dec 31, 2021 | 21.35M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Viva Biotech Holdings | 1.92B |
| Ocumension Therapeutics | 895.09M |
| BioDlink International Company | 831.99M |
| Medtide | 634.40M |
| Mirxes Holding Company | 166.32M |
| Jacobio Pharmaceuticals Group | 59.56M |
| HJ Science | 14.54M |
| Clover Biopharmaceuticals | 3.90M |